Aim: Platelets play an important role in the pathogenesis of nephrotic syndrome, and the aim in this study is to evaluate platelet indices as markers of this disorder. Methods: A total of 39 patients with nephrotic syndrome, who were followed by the pediatric nephrology department in our center from January 2017 to January 2018, were included in the study. The participants were divided into two groups, as those with steroid-sensitive nephrotic syndrome (n= 26) and those with steroid-resistant nephrotic syndrome (n= 13). Laboratory parameters, including neutrophils, lymphocytes, white blood cells, platelet counts, mean platelet volume, platelet distribution width, plateletcrit and platelet large cell ratios were reviewed retrospectively. Similar parameters from a control group comprising 30 age- and sex-matched healthy subjects were also evaluated and compared with the study groups. Results: White blood cells, neutrophil, platelet and plateletcrit values were found to be greater in the nephrotic syndrome patients than in the controls [(10.83 ± 4.98 x103/µl, 8.96 ± 2.30 x103/µl, P= 0.043), (6.96 ± 4.95 x103/ µl, 4.54 ± 2.39 x103/ µl, P=0.010), (379.49 ± 120.87 x103/µl, 328.83 ± 69.42 x103/ µl, P=0.032), (0.38 ± 0.11%, 0.33 ± 0.06%, P=0.012) respectively]. Plateletcrit values were greater in the steroid-resistant nephrotic syndrome group when compared to the control group (0.42 ± 0.14%, 0.33 ± 0.06%) (P= 0.007). Conclusion: Plateletcrit could serve as a marker for steroid-resistant nephrotic syndrome, although further studies involving larger samples should be carried out to determine changes in platelet indices that occur in association with nephrotic syndrome.
Amaç: Trombositlerin nefrotik sendrom patogenezinde önemli rolü vardır. Bu çalışmada trombosit indekslerinin nefrotik sendromda belirteç olarak kullanılması araştırıldı. Yöntem: Ocak 2017-Şubat 2018 tarihleri arasında merkezimizde Çocuk Nefroloji Polikliniği’nde takip edilen 39 hasta çalışmaya dahil edildi. Katılımcılar, steroide duyarlı nefrotik sendrom (n= 26) ve steroide dirençli nefrotik sendrom (n= 13) olarak iki gruba ayrıldı. Hastaların nötrofil, lenfosit, lökosit, trombosit sayıları, ortalama trombosit hacmi, trombosit dağılım genişliği, platelekrit ve trombosit sayıları retrospektif olarak elde edildi. Yaş ve cins olarak uyumlu 30 sağlıklı kontrolden de aynı parametreler elde edildi ve hasta grubuyla karşılaştırıldı. Bulgular: Hasta grubunda kontrol grubuna göre sırasıyla lökosit, nötrofil, trombosit ve platelekrit değerleri daha yüksek saptandı [(10.83 ± 4.98 x103/µl, 8.96 ± 2.30 x103/µl, P= 0.043), (6.96 ± 4.95 x103/ µl, 4.54 ± 2.39 x103/ µl, P=0.010), (379.49 ± 120.87 x103/µl, 328.83 ± 69.42 x103/ µl, P=0.032), (0.38 ± 0.11%, 0.33 ± 0.06%, P=0.012) ]. Steroid direnci açısından değerlendirildiğinde steroide dirençli nefrotik sendrom grubunda platelekrit değeri kontrole göre daha yüksek bulundu (%0.42 ± 0.14, %0.33 ± 0.06) (P= 0.007). Sonuç: Platelekrit, steroide dirençli nefrotik sendromda steroid direncini gösteren bir belirteç olarak kullanılabilir. Bu bulguyu desteklemek için daha geniş hasta grubuyla çalışmalar yapılmalıdır.
Primary Language | Turkish |
---|---|
Subjects | Health Care Administration |
Journal Section | Articles |
Authors | |
Publication Date | August 26, 2020 |
Submission Date | March 4, 2020 |
Acceptance Date | June 2, 2020 |
Published in Issue | Year 2020 Volume: 13 Issue: 2 |
MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.
Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.
Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.
Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.
Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.
Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.
This work is licensed with Attribution-NonCommercial 4.0 International.